*
Strongly Agree Agree Neutral Disagree Strongly Disagree
IDENTIFY the mechanism of action of CAR-Ts and their role in hematologic cancer treatment regimens.
REVIEW the CAR-Ts recently-approved and in-development for hematology/oncology care.
OUTLINE possible CAR-T-related AEs and their implications for hematology/oncology HCPs.
*
Excellent Very Good Good Fair Poor N/A
Overall evaluation
Course content
Usefulness
Syllabus materials
*
*
*
Strongly Agree Agree Neutral Disagree Strongly Disagree
Medical or Practice Knowledge
Care Attitudes
Procedural or Cognitive Skills
Practice Behavior Strongly
Patients’ Clinical Outcomes
*
*
*
*